PRESS RELEASE For immediate release QUEBEC, Québec, February 7, 2025 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today announced...
Press Releases
DEVONIAN HEALTH GROUP INC. REPORTS SUPERIOR ANTI-INFLAMMATORY POTENCY OF THYKAMINE™ IN COMPARATIVE IN VITRO STUDY
PRESS RELEASE For immediate release In vitro study demonstrated superior potency of Thykamine™ against various corticosteroids and a phosphodiesterase inhibitor Supports the clinical efficacy results of Thykamine™ in previous and ongoing studies in the treatment of...
DEVONIAN APPOINTS VIKTORIA KRASTEVA AS CHIEF FINANCIAL OFFICER
PRESS RELEASE For immediate release DEVONIAN APPOINTS VIKTORIA KRASTEVA AS CHIEF FINANCIAL OFFICER QUÉBEC, Québec, January 21, 2025 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on...